On May 16, 2025, President Joe Biden was diagnosed with advanced prostate cancer with metastasis to the bone, diagnosed as metastatic prostate cancer. The medical team assessed a Gleason score of 9, indicating a very aggressive prostate cancer. . His doctors pointed out that the cancer is hormone-sensitive when it still responds to treatment that reduces giving testosterone; which was hopeful considering the metastatic process . His office stated he and his family are “consulting with his physicians on treatment options”, and confirmed he is taking the oral therapy for six weeks starting in the later part of May .
Read more- Intensified Airstrikes in Gaza Leave Over 74 Dead
Treatment Prospects and Outlook
Metastatic prostate cancer is not curable, however, the hormone-sensitive type offers treatments that can control the disease for many years. Other treatments can include chemotherapy, targeted radiation (notably for bone lesions), and bisphosphonate-type drugs to prevent destruction or weakness of bones.
Why It Was Not Caught Sooner—and Broader Lessons
Experts have raised questions about why this aggressive cancer was not diagnosed sooner. Also, some aggressive tumors simply may not raise PSA levels sufficiently, or could have developed between intermittent tests.
The incident highlights the necessity for individualized screening recommendations for older men – weighing the benefits of early detection versus overtesting.
Conclusion
The announcement that President Biden has metastatic, hormone sensitive prostate cancer highlights the complexity and progress in the treatment of cancer. Furthermore, this also draws attention to the issue of targeted screening and engagement in shared decision-making regarding prostate health and treatment priorities among more older adults. The next few months will be significant as to how Mr. Biden responds to initial treatment and adjustment of care. click here for the source
